Catalyst Wire Dossier Catalyst Wire Dossier

Folate receptor alpha peptide vaccine with GM-CSF

· Marker Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Folate receptor alpha peptide vaccine with GM-CSF, covering 2021-07-19 to 2022-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer [Phase 2]

See pricing